Reta Research Roundup

I've updated the initial post with several additional articles on retatrutide. I can't share personal experiences yet, as I haven't started using it. Actually, I'm seeing better results with tirzepatide now than before, so I might not even use the reta I purchased. Still, I'm keeping it as a backup plan.
 
Updated list, part 1:

Reta Sources

https://pmc.ncbi.nlm.nih.gov/articles/PMC12026077/

Eur. J. Pharmacol. 177095

EClinicalMedicine, 75, 102782

Drugs Context, 2025-14, 4-8.

doi.org/10.1038/s41574-024-00979-9

Advances Clin. Pharmacology & Therapeutics 2(2), 47.

Medscape.

Peptides 173, 171149.

World journal of diabetes, 16(9), 109123.

World J. Cardiol., 17(8), 107991.

New Engl. J. Med. 389(17), 1628.

Lekarz Wojskowy 103(3), 167-175.

Quality in Sport, 15, 52125-52125.

Gastroenterology Rep. 12, goae029.

World J. Gastroentereol., 31(37), 111435.

Cell Metabolism 34(9), 1234-1247.e9

Diabetologie und Stoffwechsel, 19(S 01), S72-S73.

Lancet Diabetes Endocrinology 13, 674.

J. Pharm. Technol. 300.

Expert opinion on investigational drugs, 32(5), 355-359.

Expert Opn. Investigational Drugs 32(11), 997-1001.

Diabetes Care 47(11), 1873-1888.

New Engl. J. Med. 389(17), 1629.

Diabetes Obesity & Metabolism.

Obesity Pillars 16, 100220.

Curr. Cardiovascular Risk Reps., 19(18), 17.

Obesity Pillars 13, 100162.

Diabetes Therapy, 15, 1069–1084.
 
Updated list, part 2:

List of Reta Sources

Curr. Opn. Endocrinology Diabetes & Obesity 31(3), 115-121.

New England Journal of Medicine, 389(6), 514–526. Research Summary: Protocol; Supplementary Appendix. https://doi.org/10.1056/nejmoa2301972

New Engl. J. Med. 389(17), 1629-1630.

Diabetes Obesity & Metabolism, https://doi.org/10.1111/dom.70097.

Biomolecules 15(6), 796.

Eur. J. Clin. Pharmacol. 80, 669-676.

Pharmacological Rev. 77(1), 100002.

Expert Opinion on Pharmacotherapy, 25(2), 131-138.

Cell Discovery 10(1), 77.

npj Metab Health Dis 3, 10.
 
I've been experimenting with reta for a little while now. I couldn't tolerate semaglutide at even low doses; just wicked nausea. But Reta is different. Started at 2mg a week, split into two doses, and I feel pretty good! No nausea, and my appetite is way down. I can still eat, but I don't want to eat as much.
 
It's interesting that these sources can synthesize it already even before it's fully through clinical trials.
 
My wife's been on it for about half a year, taking two doses of 3mg per week. She's lost around 50 pounds, watching her diet and training. I had to stop because it gave me wicked insomnia. I might try again at smaller doses to see if I can adapt. It might not be for me. I did find a great source though.
 
I've seen some folks ordering reta from overseas suppliers. If you do that, I'd suggest sending a sample to a lab like Janoshik for testing. They're pretty reliable and can verify the purity. Expect results in a few weeks.
 
SunnyCookie said:
It IS amazing what these drugs can do, if they ever become affordable nobody would be overweight anymore.

That's not entirely correct. Without ongoing lifestyle modifications, higher dosages are often needed over time to maintain the initial benefits. Eventually, tolerance can develop even at the highest tolerable dose, leading to weight regain despite continued use of the medication. This process can take several years, but it doesn't seem to be a permanent fix without lifestyle changes.
 
The FDA gap on those IG ads is a known frustration - the research-only carveout creates enough ambiguity that the enforcement bar is high even when the claims are clearly commercial. Reddit peptide communities having a rough quality of signal is something a lot of people experience before finding a place with actual moderated discussion. The research roundup in the OP is exactly the kind of organized resource that makes a difference for someone trying to actually understand the pharmacology before committing to a protocol - glad you found it before going in blind.
 
Back
Top